Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 26.64 Min. order: 1 piece ★★★★★ 4.7 (76 reviews) Sold : Login>>
FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway - Han - 2022 - Journal of Cellular and Molecular Medicine US$ 22.90 Min. order: 1 piece ★★★★★ 4.2 (244 reviews) Sold : Login>>